HCPCS Level II
J9345
Injection, retifanlimab-dlwr, 1 mg
Codes near J9345
These sit next to J9345 in the CMS Level II file. All J codes
- J9333Injection, rozanolixizumab-noli, 1 mg
- J9334Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
- J9340Injection, thiotepa, 15 mg
- J9341Injection, thiotepa (tepylute), 1 mg
- J9342Injection, thiotepa, not otherwise specified, 1 mg
- J9347Injection, tremelimumab-actl, 1 mg
- J9348Injection, naxitamab-gqgk, 1 mg
- J9349Injection, tafasitamab-cxix, 2 mg
- J9350Injection, mosunetuzumab-axgb, 1 mg
- J9351Injection, topotecan, 0.1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 50881-0006-03 | Zynyz | Incyte Corporation | 500 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.